Substance Use Disorder Flashcards

1
Q

Most important element

A

Build a trusting relationship with the

patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Assessment for SUD

A
Obtain a thorough medical history
• Know s/s of substance use,
withdrawal symptoms specific to each
substance
• Build a trusting relationship with the
patient
• Non-judgmental, empathetic attitude
• Be aware of resources in the community
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ETOH Intoxication S/S

A

Slurred speech, Dizziness,
Incoordination, Unsteady gait,
Nystagmus, Impaired attention/memory,
Coma or double vision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ETOH Withdrawal 8 to 12 hours

A
Autonomic hyperactivity (hight BP, increased heart rate etc);
Perceptual disturbances and hallucinations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ETOH Withdrawal 12-24 hours

A

Generalized/tonic-clonic seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ETOH Withdrawal other

A

Nausea, vomiting; can be life-threatening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CIWA Categories

A
Agitation (0–7)
Anxiety (0–7)
Auditory Disturbances (0–7)
Clouding of Sensorium (0–4)
Headache (0–7)
Nausea/Vomiting (0–7)
Paroxysmal Sweats (0–7)
Tactile disturbances (0–7)
Tremor (0–7)
Visual disturbances (0–7)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CIWA <10

A

supportive, n on-pharmacologic therapy and close monitoring are indicated )unless patient has hx of alchol withdrawl seizures or co-morbid cardiovascular conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CIWA 10 - 15

A

Lorazepam is indcated to reduce symptoms and the risk of major complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CIWA >15

A

Strong consideration should be given to hospitalizing inmates who exhibit severe symptoms, as they are at increased risk for serious complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ETOH WD treatment drugs

A

Benzodiazepines, anticonvulsants
(carbamazepine, gabapentin), clonidine,
propranolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ETOH treament supplement

A

Thiamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why do we use thiamine

A

B1 deficiency can occur with chronic ETOH use. This results in wernkeis encephalopathy. Confusion CNS effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Naltrexone

A

mu opioid receptor antagonist - used in ETOH disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acamprosate used in ETOH MOA

A

binds to and blocks glutamate

receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Disulfiram

A

irreversibly inhibits aldehyde

dehydrogenase preventing metabolism of alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Opioid Intoxication S/S

A
Pinpoint pupils; Psychomotor
retardation, “nodding off;” Drowsiness,
slurred speech; Impaired memory and
attention; Reduced respirations, respiratory
depression or distress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Opioid Withdrawal

A

Dilated pupils, yawning, runny
nose/tearing; Piloerection; Restlessness,
muscle aches; Stomach cramps, diarrhea,
tachycardia; tremors (less common), hot/cold
sweats, insomnia; feels life threatening to the
person

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

COWS categories.

A
Resting heart rate (0–4)
Gastrointestinal upset in past
30 minutes (0–5)
Sweating (0–4)
Tremor of hands (0–4)
Restlessness (0–5)
Yawning during assessment (0–4)
Pupil size (0–5)
Anxiety or irritability (0–4)
Bone or joint aches associated with
withdrawal (0–4)
Gooseflesh skin (0–5)
Runny nose or tearing (0–4)
20
Q

COWS mild

A

5-12

21
Q

COWS Moderate

A

13-24

22
Q

COWS moderately severe

A

21-36

23
Q

COWS severe

A

36

24
Q

Treatment of opoids includes

A

alpha-2 adrenergic

agonists

25
Q

Drugs used to treat OUD

A

Buprenophine, Methadone, Nextrexone, Naloxone

26
Q

Bupreophine class

A

mu receptor partial agonist

27
Q

Methadone class

A

Full opoid agonist

28
Q

Naltrexone class

A

mu opoid receptor atnagonist

29
Q

Benzo withdrawal symptoms

A

sx similar to alcohol

withdrawal

30
Q

Benzo withdrawal starts

A

starts 2-3 days after cessation
or up to 5 with long acting; can be life
threatening

31
Q

Do not prescribe ____ on a long term basis

A

benzos

32
Q

Cannabis Intoxication S/S

A

Red eyes (dilation of conjunctival
blood vessels, mild tachycardia, dry mouth;
Heightened sensitivity to environmental stimuli,
Slowing perception of time; Depersonalization,
Derealization; Impaired memory, increased
appetite; Delirium, paranoia, or psychosis;
Impaired motor skills and attention

(up to 8 to
12 hours after use)

33
Q

Cannabis Withdrawal starts

A

1-2 weeks of cessation

34
Q

Cannabis S/S

A

Irritability, cravings, headaches;
Anxiety/restlessness, tremors; Insomnia, vivid
dreams; Decreased appetite, wt loss, stomach
pain; Hyperemesis syndrome

35
Q

Nicotinic acetylcholine receptor agonist - half life

A

2 hour

36
Q

Nicotine activates

A

dopamine vTa pathway,
increases endogenous epinephrine and
norepinephrine

37
Q

nicotine has

A

stimulant effects on the body

38
Q

Nicotine intoxication

A

skeletal muscle relaxation, improved

attention, learning, reaction time and probelm- solving (short term); decreased appetite

39
Q

Nicotine withdrawal begins

A

within 2 hours and peaks 24 to 48 hours

40
Q

Nicotine withdral S/S

A

Insomnia; Increased coughing (short- term); Irritability, cravings, tension; Increased
appetite, weight gain; Poor focus

41
Q

Nicotine Replacement therapy

A

Relieve nicotine withdrawal symptoms by providing nicotine

without the use of tobacco

42
Q

NRT Side Effects

A

common to all NRT: GI symptoms, HA, local irritation

43
Q

NRT forms

A

Patch, gum, lozenges, inhalers, nasal spray, mouth spray, SL

tablets

44
Q

Varenicline (Chantix)

A

partial nicotine agonist

45
Q

Varenicline (Chantix) MOA and use

A

Reduces the symptoms of nicotine withdrawal
• Blocks nicotine from binding to the receptor that mediates the
reinforcing effects of nicotine that leads to nicotine dependence.
• Reduces rewarding aspects of cigarette smoking.

46
Q

Bupropion (Zyban)

A

antidepressant,

47
Q

Bupropion (Zyban) MOA and use

A

dopamine/norepinephrine-reuptake inhibitor

• Enhances CNS noradrenergic and dopaminergic release